Clinical trial Recruiting at 14 sites Interventional Ages 50 and up Men only

Long-term evaluation of ProACT therapy for stress urinary incontinence in men

Official title: Post Approval Study of the ProACT™ Adjustable Continence Therapy for Men

Run by Uromedica · NCT03767595 · Data updated 2026-11-12

This study is testing how well the ProACT therapy works for men with stress urinary incontinence after prostate surgery and checking for any long-term issues with the treatment.

More Stress Urinary Incontinence trials

Quick facts

Study typeInterventional
Ages50 Years and up
SexMen only
Enrollment145 (estimated)
SponsorUromedica
Industry-sponsored
Drugs / interventionsradiation
Locations14 sites (Los Angeles, California and 13 other locations)
StatusRecruiting
StartedFebruary 19, 2019
Main results expectedDecember 31, 2031
Study endsDecember 31, 2031
Registry record updatedOctober 6, 2026
Trial IDNCT03767595 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are men aged 50 and older who have stress urinary incontinence and have previously undergone prostate surgery.

Probably not a fit

Patients with active urogenital malignancies or those who do not meet the inclusion criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The ProACT Post Approval Study is a five-year, prospective, open-label, multi-center evaluation aimed at assessing the long-term effects of ProACT Adjustable Continence Therapy in men who have undergone prostate surgery. This study will monitor the incidence of urethral stricture and device erosion following ProACT implantation, as well as the impact of this treatment on clinical outcomes after subsequent therapies for stress urinary incontinence. Participants will be required to undergo annual follow-up interviews to track their progress and any complications over the study period.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the long-term safety and efficacy of ProACT therapy, potentially improving treatment options for men suffering from stress urinary incontinence.

How similar studies have gone: While this study builds on existing knowledge of ProACT therapy, it specifically focuses on long-term outcomes, which may provide new insights into its effectiveness and safety.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Subject is a male of at least 50 years of age.
2. Subject demonstrates stress urinary incontinence.
3. Subject has undergone a radical prostatectomy, transurethral resection of the prostate, or other prostate surgery.
4. Subject is willing and able to undergo surgical implantation of ProACT devices.
5. Subject is willing and able to comply with study-required

   follow-up activities, including annual telephonic follow -up interviews, for a period of 5 years from their date of initial implantation. This includes compliance even after possible explant of ProACT devices and/or possible implantation of subsequent therapies.
6. Subject is willing and able to sign the approved informed consent.
7. Subject has two positive 24-hour pad weight tests (greater than or equal to 8 gram pad weight increase demonstrated in two 24-hour pad weight tests).
8. Subject has a negative urine culture.
9. Subject has no known urogenital malignancy, other than previously treated prostate cancer.
10. Subject meets ONE of the following criteria:

    1. Baseline Prostate-Specific Antigen (PSA) of less than or equal to 2.5ng/mL;
    2. Baseline PSA \> 2.5ng/mL and less than or equal to 10 ng/mL AND free PSA greater than or equal to 25% of total PSA;
11. Physician determines subject to be a suitable surgical candidate.

Exclusion Criteria:

1. Subject has an existing urethral stricture, a history of any urethral strictures, or has ever had a urethrotomy.
2. Subject has undergone prostate surgery or any anti-incontinence surgery within the last 12 months.
3. Subject has an artificial urinary sphincter or any components of a previously implanted artificial urinary sphincter in vivo.
4. Subject has undergone radiation therapy in the prostatic area within the last 12 months.
5. Subject has untreated or unsuccessfully treated detrusor instability or over-activity.
6. Subject has an atonic bladder.
7. Subject had, presently has, or is suspected of having bladder cancer.
8. Subject has untreated or unsuccessfully treated bladder stones.
9. Subject has detrusor sphincter dyssynergia.
10. Subject has known hemophilia or a bleeding disorder.
11. Subject has a known severe contrast solution allergy (e.g., anaphylaxis, cardiac, or respiratory arrest).
12. Subject has insulin-dependent diabetes that is uncontrolled or not controllable, as indicated by an A1c test result of = 6.5%.

Where it's running

  • University of Southern California
    Los Angeles, California, United States
    Recruiting
  • Sutter Health
    Santa Barbara, California, United States
    Recruiting
  • University of Colorado
    Denver, Colorado, United States
    Recruiting
  • University of Florida
    Gainesville, Florida, United States
    Recruiting
  • Urological Research Network Corp
    Hialeah, Florida, United States
    Recruiting
  • Emory University
    Atlanta, Georgia, United States
    Recruiting
Show 8 more locations
  • University of Kansas Medical Center
    Kansas City, Kansas, United States
    Recruiting
  • University of Michigan
    Ann Arbor, Michigan, United States
    Recruiting
  • CentraCare- St. Cloud
    Saint Cloud, Minnesota, United States
    Recruiting
  • CHI Health Research
    Omaha, Nebraska, United States
    Recruiting
  • Lehigh Valley Health Network
    Allentown, Pennsylvania, United States
    Recruiting
  • Allegheny Health Network
    Pittsburgh, Pennsylvania, United States
    Recruiting
  • Urology Partners of North Texas Research Institute
    Arlington, Texas, United States
    Recruiting
  • DHR Health Institute for Research and Development
    McAllen, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.